JP2022540877A5 - - Google Patents
Info
- Publication number
- JP2022540877A5 JP2022540877A5 JP2022502075A JP2022502075A JP2022540877A5 JP 2022540877 A5 JP2022540877 A5 JP 2022540877A5 JP 2022502075 A JP2022502075 A JP 2022502075A JP 2022502075 A JP2022502075 A JP 2022502075A JP 2022540877 A5 JP2022540877 A5 JP 2022540877A5
- Authority
- JP
- Japan
- Prior art keywords
- immunotoxin
- amino acid
- cx3cr1
- sequence
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19186000 | 2019-07-12 | ||
| EP19186000.6 | 2019-07-12 | ||
| PCT/EP2020/067785 WO2021008840A1 (en) | 2019-07-12 | 2020-06-25 | Fusion toxin proteins for treatment of diseases related to cmv infections |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022540877A JP2022540877A (ja) | 2022-09-20 |
| JP2022540877A5 true JP2022540877A5 (cg-RX-API-DMAC7.html) | 2023-06-12 |
Family
ID=67437717
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022502075A Pending JP2022540877A (ja) | 2019-07-12 | 2020-06-25 | Ｃｍｖ感染に関連する疾患の治療のための融合毒素タンパク質 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20220281933A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3997107A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2022540877A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20220032610A (cg-RX-API-DMAC7.html) |
| CN (1) | CN114206944A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2020312560A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112022000417A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3146798A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2022000433A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021008840A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2603166A (en) * | 2021-01-29 | 2022-08-03 | Thelper As | Therapeutic and Diagnostic Agents and Uses Thereof |
| EP4301394A1 (en) * | 2021-03-03 | 2024-01-10 | Synklino ApS | Compositions for ex vivo organ care |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002018954A2 (en) * | 2000-08-30 | 2002-03-07 | Chemocentryx, Inc. | Inhibition of cmv infection and dissemination |
| CA2437201C (en) * | 2001-02-02 | 2008-11-18 | Chemocentryx, Inc. | Methods and compositions useful for stimulating an immune response |
| EP2038302B1 (en) * | 2006-07-03 | 2012-10-24 | INAGEN ApS | Immunotoxins for the treatment of diseases related to cmv infection |
| WO2010070394A1 (en) * | 2008-12-17 | 2010-06-24 | Universite Pierre Et Marie Curie-Paris Vi | Modulators of the cx3cr1 receptor and therapeutic uses thereof |
| TWI570240B (zh) * | 2011-09-09 | 2017-02-11 | 默沙東公司 | 作為細胞巨大病毒疫苗之條件式複製ｃｍｖ |
| EP3262063B1 (en) * | 2015-02-26 | 2021-09-22 | Var2 Pharmaceuticals ApS | Immunotherapeutic targeting of placental-like chondroitin sulfate using chimeric antigen receptors (cars) and immunotherapeutic targeting of cancer using cars with split-protein binding systems |
| US10849960B2 (en) * | 2017-09-08 | 2020-12-01 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Synergistic combination of IL-4, interferon gamma, and interferon alpha in treating ovarian cancer |
-
2020
- 2020-06-25 CN CN202080050524.5A patent/CN114206944A/zh active Pending
- 2020-06-25 WO PCT/EP2020/067785 patent/WO2021008840A1/en not_active Ceased
- 2020-06-25 KR KR1020227004798A patent/KR20220032610A/ko not_active Ceased
- 2020-06-25 BR BR112022000417A patent/BR112022000417A2/pt unknown
- 2020-06-25 JP JP2022502075A patent/JP2022540877A/ja active Pending
- 2020-06-25 AU AU2020312560A patent/AU2020312560A1/en not_active Abandoned
- 2020-06-25 EP EP20734206.4A patent/EP3997107A1/en not_active Withdrawn
- 2020-06-25 CA CA3146798A patent/CA3146798A1/en active Pending
- 2020-06-25 US US17/626,675 patent/US20220281933A1/en not_active Abandoned
- 2020-06-25 MX MX2022000433A patent/MX2022000433A/es unknown